Gynica and Lumir Lab announced they have formed a partnership focused on finding a cannabis-based treatment for endometriosis, a topic discussed in a recent Forbes article featuring Lara Parker.
Gynica’s preclinical trial of a cannabinoid-based treatment for endometriosis is already showing promising results. The study is led by Prof. Lumir Ondrej Hanus, the chemist responsible for the definition and isolation of active cannabinoid compounds in 1992.
10 oct 2018
Gynica, Lumir Lab, and Canadian startup Strainprint have announced a partnership to develop the world’s first and largest database of the effects of cannabis on women, starting with a focus on endometriosis symptoms.